![Mohammed Afshar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mohammed Afshar is the founder.
Dr. Afshar was the founder of Ariana Pharmaceuticals SA, serving as Chief Executive Officer & Director since 2003.
Dr. Afshar is also the founder of RiboTargets Ltd. Former job at The University of York as Research Fellow.
Former job at Génomic Vision SA as Member-Supervisory Board.
Education at Université de Montpellier with undergraduate, graduate, and doctorate degrees.
| Companies | Position | End |
|---|---|---|
Ariana Pharmaceuticals SA
 Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology | Founder | 2024-08-07 |
| GENOMIC VISION | Director/Board Member | - |
The University of York
 The University of York Other Consumer ServicesConsumer Services Functions as a College/University | Chief Tech/Sci/R&D Officer | - |
RiboTargets Ltd.
 RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company | Founder | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
RiboTargets Ltd.
RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company | Health Technology |
Université de Montpellier
 Université de Montpellier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of York
The University of York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology | Health Technology |
Génomic Vision SA
 Génomic Vision SA Medical SpecialtiesHealth Technology Develops diagnostic tools using deoxyribonucleic acid analysis | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
